These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients? Aydin N; Topsever P; Kaya A; Karasakal M; Duman C; Dağar A Tohoku J Exp Med; 2004 Mar; 202(3):173-80. PubMed ID: 15065643 [TBL] [Abstract][Full Text] [Related]
11. Weight management and current options in pharmacotherapy: orlistat and sibutramine. Leung WY; Thomas GN; Chan JC; Tomlinson B Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112 [TBL] [Abstract][Full Text] [Related]
12. Orlistat improves endothelial function in obese adolescents: a randomised trial. Yu CC; Li AM; Chan KO; Chook P; Kam JT; Au CT; So RC; Sung RY; McManus AM J Paediatr Child Health; 2013 Nov; 49(11):969-975. PubMed ID: 23735004 [TBL] [Abstract][Full Text] [Related]
13. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Erondu N; Addy C; Lu K; Mallick M; Musser B; Gantz I; Proietto J; Astrup A; Toubro S; Rissannen AM; Tonstad S; Haynes WG; Gottesdiener KM; Kaufman KD; Amatruda JM; Heymsfield SB Obesity (Silver Spring); 2007 Aug; 15(8):2027-42. PubMed ID: 17712121 [TBL] [Abstract][Full Text] [Related]
14. Reproducibility of laser Doppler fluximetry and the process of iontophoresis in assessing microvascular endothelial function using low current strength. Al-Tahami BA; Yvonne-Tee GB; Halim AS; Ismail AA; Rasool AH Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):181-5. PubMed ID: 20448860 [TBL] [Abstract][Full Text] [Related]
15. Influence of eating behaviors on short-term weight loss by orlistat and anorectic agent. Kim KK; Suh HS; Hwang IC; Ko KD Eat Behav; 2014 Jan; 15(1):87-90. PubMed ID: 24411757 [TBL] [Abstract][Full Text] [Related]
16. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Muls E; Kolanowski J; Scheen A; Van Gaal L; Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595 [TBL] [Abstract][Full Text] [Related]
17. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England. Perrio MJ; Wilton LV; Shakir SA Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762 [TBL] [Abstract][Full Text] [Related]
18. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Bergholm R; Tiikkainen M; Vehkavaara S; Tamminen M; Teramo K; Rissanen A; Yki-Järvinen H Diabetes Care; 2003 Jun; 26(6):1667-72. PubMed ID: 12766091 [TBL] [Abstract][Full Text] [Related]
19. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study. Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651 [TBL] [Abstract][Full Text] [Related]
20. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial. Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]